Patents by Inventor Philip A. Iredale

Philip A. Iredale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
    Publication number: 20040224962
    Abstract: Pharmaceutical compositions are disclosed for the treatment of obesity, an overweight condition and compulsive overeating. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotinic receptor partial agonist and a CB-1 receptor antagonist and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.
    Type: Application
    Filed: March 3, 2004
    Publication date: November 11, 2004
    Applicant: Pfizer Inc
    Inventors: Jotham W. Coe, Philip A. Iredale, Steven B. Sands
  • Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
    Publication number: 20040224963
    Abstract: Pharmaceutical compositions are disclosed for the treatment of nicotine dependence or addiction, tobacco dependence or addiction, reduction of nicotine withdrawal symptoms or aiding in the cessation or lessening of tobacco use or substance abuse or other behavioral dependencies. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotinic receptor partial agonist and a CB-1 receptor antagonist and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.
    Type: Application
    Filed: March 4, 2004
    Publication date: November 11, 2004
    Applicant: Pfizer Inc
    Inventors: Jotham W. Coe, Philip A. Iredale, Steven B. Sands